BROWSE·page 273 of 611

Browse EX-10 agreements

7,325 matching material contract exhibits.


EX-10.1

Beachbody Company, Inc.

EXECUTION VERSION

AMENDMENT NO. 2 TO CREDIT AGREEMENT

THIS AMENDMENT NO. 2 TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of this 3rd day of August, 2026 by and among (i) THE BEACHBODY COMPANY, INC., a Delaware corporation (“Parent”), (ii) BEACHBODY, LLC, a Delaware limited liability company and a wholly-owned Subsidiary of Parent (the “Administrative Borrower”, and together with Parent, each direct and indirect Subsidiary of the Administrative Borrower listed as a Borrower on the signature pages hereto, and any additional Person joined as a borrower, each individually, a “Borrower”, and jointly and severally, collectively, “Borrowers”), (iii) each Guarantor, (iv) each lender party hereto (collectively, the “Lenders” and individually, a “Lender”), and (v) TIGER FINANCE, LLC, as administrative agent and collateral agent under the Loan Documents (together with any successors and assigns in such capacities, “Agent”).

WITNESETH:

…

EX-10.1·8-K·CIK 1826889·ACC 0001193125-26-337988·Filed Aug 06, 2026, 16:09 ET

EX-10.1

Aimei Health Technology Co., Ltd.

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

Principal Amount: US$34,330.96

Dated: August 6, 2026

…

EX-10.1·8-K·CIK 1979005·ACC 0001493152-26-036336·Filed Aug 06, 2026, 16:06 ET

EXHIBIT 10.1

Grace Therapeutics, Inc.


Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of August 4, 2026, by and among Grace Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated under the Securities Act;

…

EX-10.1·8-K·CIK 1444192·ACC 0001140361-26-031671·Filed Aug 06, 2026, 16:06 ET

EXHIBIT 10.2

Grace Therapeutics, Inc.


Exhibit 10.2

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT(this “Agreement”), dated as of August 4, 2026, is entered into by and among Grace Therapeutics, Inc., a Delaware corporation (the “Company”), and the several investors signatory hereto(individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

…

EX-10.2·8-K·CIK 1444192·ACC 0001140361-26-031671·Filed Aug 06, 2026, 16:06 ET

EX-10.1

ARROW ELECTRONICS, INC.

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made as of July 31, 2026, by and between Arrow Electronics, Inc. (the “Company”), and Deidra C. Merriwether (“Executive”) (together, the “Parties”).

RECITALS

WHEREAS, the Company desires to employ Executive as its President and Chief Operating Officer; and

WHEREAS, Executive has agreed to accept employment on the terms and conditions set forth in this Agreement;

NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements of the Parties herein contained, the Parties hereto agree as follows:

1. Agreement. This Agreement shall be effective as of Executive’s commencement of employment with the Company on September 8, 2026 or such other date as the Parties may agree (the “Effective Date”). Following the Effective Date, Executive shall be an employee of the Company until such employment relationship is terminated in accordance with Section 7 hereof (the “Term of Employment”).

…

EX-10.1·8-K·CIK 7536·ACC 0000007536-26-000127·Filed Aug 06, 2026, 16:04 ET

EXHIBIT 10.1

AMERICAN HONDA RECEIVABLES LLC

EXHIBIT 10.1

AMERICAN HONDA FINANCE CORPORATION,
as RPA Seller,

and

AMERICAN HONDA RECEIVABLES LLC,
as Purchaser

RECEIVABLES PURCHASE AGREEMENT

Dated August 12, 2026

TABLE OF CONTENTS

Page
Article I DEFINITIONS 1

…

EX-10.1·8-K·CIK 890975·ACC 0001104659-26-091799·Filed Aug 06, 2026, 11:29 ET

EXHIBIT 10.3

AMERICAN HONDA RECEIVABLES LLC

HONDA AUTO RECEIVABLES 2026-3 OWNER TRUST,
as Issuer,

AMERICAN HONDA FINANCE CORPORATION,
as Sponsor and Administrator,

AMERICAN HONDA RECEIVABLES LLC,
as Depositor,

and

CITIBANK, N.A.,
as Indenture Trustee

ADMINISTRATION AGREEMENT

Dated August 12, 2026

Table of Contents

Page

Section 1.01 Capitalized Terms; Interpretive Provisions. 2
Section 1.02 Duties of the Administrator. 2
Section 1.03 Records 9
Section 1.04 Compensation 9
Section 1.05 Additional Information to be Furnished to the Issuer 9
Section 1.06 Independence of the Administrator 9

…

EX-10.3·8-K·CIK 890975·ACC 0001104659-26-091799·Filed Aug 06, 2026, 11:29 ET

EXHIBIT 10.2

AMERICAN HONDA RECEIVABLES LLC

EXHIBIT 10.2

HONDA AUTO RECEIVABLES 2026-3 OWNER TRUST,
as Issuer,

AMERICAN HONDA RECEIVABLES LLC,
as Seller,

and

AMERICAN HONDA FINANCE CORPORATION,
as Servicer, RPA Seller and Sponsor

SALE AND SERVICING AGREEMENT

Dated August 12, 2026

Table of Contents

Page

…

EX-10.2·8-K·CIK 890975·ACC 0001104659-26-091799·Filed Aug 06, 2026, 11:29 ET

EXHIBIT 10.4

AMERICAN HONDA RECEIVABLES LLC

AMERICAN HONDA RECEIVABLES LLC,
as Depositor,

THE BANK OF NEW YORK MELLON,
as Owner Trustee

and

BNY MELLON TRUST OF DELAWARE,
as Delaware Trustee

_______________________________

AMENDED AND RESTATED
TRUST AGREEMENT

Dated August 12, 2026

_______________________________

Table of Contents

Page

Article I
DEFINITIONS
Section 1.01. General Definitions 1

…

EX-10.4·8-K·CIK 890975·ACC 0001104659-26-091799·Filed Aug 06, 2026, 11:29 ET

EXHIBIT 10.5

AMERICAN HONDA RECEIVABLES LLC

EXHIBIT 10.5

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

HONDA AUTO RECEIVABLES 2026-3 OWNER TRUST,
as Issuer,

AMERICAN HONDA FINANCE CORPORATION,
as Sponsor and Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,
as Asset Representations Reviewer

Dated as of August 12, 2026

Table of Contents

Page

…

EX-10.5·8-K·CIK 890975·ACC 0001104659-26-091799·Filed Aug 06, 2026, 11:29 ET

EX-10.2

STAAR SURGICAL CO

STAAR SURGICAL COMPANY

AMENDED AND RESTATED OMNIBUS EQUITY INCENTIVE PLAN

STOCK OPTION GRANT NOTICE

STAAR Surgical Company, a Delaware corporation, (the “Company”), pursuant to its Amended and Restated Omnibus Equity Incentive Plan, as may be amended from time to time (the “Plan”), hereby grants to the individual listed below (“Participant”), in consideration of the mutual agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, an option to purchase the number of shares of the Company’s Common Stock (“Stock”), set forth below (the “Option”). This Option is subject to all of the terms and conditions set forth herein, as well as in the Plan and the Stock Option Agreement attached hereto as Exhibit A(the “Agreement”), each of which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Agreement. A Prospectus regarding the Stock is available at https://staarus.sharepoint.com/sites/STAARNET.

…

EX-10.2·8-K·CIK 718937·ACC 0001193125-26-337197·Filed Aug 06, 2026, 11:04 ET

EX-10.1

STAAR SURGICAL CO

August 4, 2026

Re: President and CEO Offer Letter Agreement

Dear Warren:

STAAR Surgical Company (the “Company”) is pleased to offer you the position of President and Chief

Executive Officer (“CEO”) pursuant to the terms and conditions of this offer letter agreement (“Agreement”), reporting to the Board of Directors of the Company (the “Board”) and effective as of August 4, 2026 (the “Start Date”). The terms of this Agreement are intended to supersede and replace the terms and conditions of your offer letter with the Company, dated March 24, 2023 (the “Original Offer Letter”) and your offer letter with the Company, dated February 1, 2026 (the “Interim CEO Offer Letter” and, together with the Original Offer Letter, the “Prior Offer Letters”), in their entirety. The terms of this Agreement are in addition to that certain Amended and Restated Severance Agreement by and between you and the Company, dated August 4, 2026 (as may be amended and/or amended and restated from time to time, the “Severance Agreement”), that certain Amended and Restated Change in Control Agreement by and betwe

…

EX-10.1·8-K·CIK 718937·ACC 0001193125-26-337197·Filed Aug 06, 2026, 11:04 ET